Market Access, Pricing, and Reimbursement

Realizing Opportunities in Pharma, MedTech, and Vaccine Industry

Why choose Alira Health for Market Access Support?

As your partner, we’ll work closely with you to uncover opportunities across the pharma industry, accelerate innovation, and deliver tomorrow’s standard of care. You’ll benefit from our:

  • Objective analysis

    Objective analysis of complex therapeutic areas, markets, pricing, and reimbursement landscapes

  • Industry expertise

    Extensive expertise in market access, pricing, health economics, and real-world evidence

  • Strategic consulting

    to define growth initiatives and accelerate market penetration. Learn more

  • An integrated team approach

    Our collaborative team works in partnership with clients, providing frequent, transparent and effective communication

  • Quality data

    High-quality outputs, substantiated by credible and established sources

  • Tailored solutions

    Our team works hard to get a clear understanding of your objectives, and designs solutions with your goal in mind

Market Access - Our Approach

market access diagram
market access medtech diagram
market access reports market access information
market access graphs

Global expertise in healthcare and life sciences

Alira Health’s market access team helps clients demonstrate value, optimize patient access, and realize the commercial opportunity for their healthcare and life sciences innovations.

Working Together for Market Access

Whether you need to understand which asset best aligns with your long-term strategy, which new market or therapeutic area to explore, or how to expand into another sector, we are ready to help you lead the way.

Contact us
Jean-François Ricci
Jean-François Ricci
Executive Vice President, Global Market Access
Our strong client partnerships allow us to deliver in-depth, customized strategies and access solutions—all designed to maximize product value across its full lifecycle.

Market Access News

Blog April 17, 2023
Reimbursement of Rare Disease Drugs in Italy: Challenges and Hopes for the Future
When it comes to rare diseases, Italy has done a good job in bringing EMA-approved drugs, including orphan drugs, to the Italian market. But  multiple challenges exist, many of which(...)
Italy Market Access Pharma Rare Disease Real-World Evidence (RWE)
Blog April 17, 2023
Pharmaceutical Market Access in the UK: A Changing Landscape
Start reading this interview with Rachel Fyson to gain insight into the changing landscape of market access in the United Kingdom.
Market Access Pharma UK
Blog April 14, 2023
Lifecycle Optimization: The Path to Commercial Success
Pharmaceutical and biotech companies constantly focus on product innovation. But how can you also increase your effectiveness in order to be as commercially competitive and efficient as possible?
Market Access MedTech Pharma
News April 5, 2023
Alira Health Joins EMIG to Advance Market Access in the UK
We are pleased to announce that Alira Health has joined the Ethical Medicines Industry Group (EMIG), a multi-stakeholder network and trade association that represents the interests(...)
Market Access Patient Centricity UK
Blog March 20, 2023
The State of Market Access in Italy 2023
To learn about the state of market access in Italy today, we spoke with Giovanni Firenze, Director of Market Access Italy for Alira Health, who attended the recent 2023 Conferenza Nazionale(...)
Drug Development Italy Market Access Pharma
Events March 6, 2023
World EPA Congress 2023
We are pleased to share that we will be participating in World EPA Congress 2023 as speakers and sponsors. World Evidence, Pricing and Access Congress is Europe’s largest congress(...)
Biotech Market Access Pharma Real-World Evidence (RWE)
Blog March 6, 2023
Market Access in Catalonia: 2022 Trends and What’s Next
Alira Health contributed to the recently published 2022 BioRegion Report, the most extensive analysis of the assets, achievements, and trends in the life sciences and healthcare sector(...)
Biotech Market Access MedTech Spain
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.